Renal involvement in amyloidosis. Clinical outcomes, evolution and survival;Afectación renal en la amiloidosis. Características clínicas, evolución y supervivencia

Nefrologia

Volumn 26, Issue 2, 2006, Pages 212-217

  Esteve, Vicente ^a,b   Almirall, J ^a   Ponz, E ^a   Garcia N ^a   Ribera, L ^a   Larrosa, M ^a   Andreu, X ^a   Garcia M ^a  

^a Hospital Universitari Parc Taulí   (Spain)

^b Parc Tauli Health Corporation   (Spain)

Author keywords

Amyloidosis; Dialysis; Renal failure; Survival

Indexed keywords

AGED; AMYLOIDOSIS; ARTICLE; FEMALE; HUMAN; INCIDENCE; KIDNEY DISEASE; MALE; MORTALITY; SURVIVAL RATE;

AGED; AMYLOIDOSIS; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; SURVIVAL RATE;

EID: 33748030770     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hawkins PN: Amyloidosis. Blood Rev 2 (4): 270-280, 1988.
2. Martínez Vea A, Torras A, Darnell A, Carrera M, Revert L: Amiloidosis primaria y secundaria renal: manifestaciones clínicas, evolución y supervivencia. Estudio comparativo de 37 pacientes. Med Clin (Barc) 80: 191-195, 1983.
3. Martínez Vázquez JM, Pigrau C, Ocaña I, Muñiz R, Capdevila JA, Ribera E: Valoración clínica de 66 casos de amiloidosis secundaria. Med Clin (Barc); 80: 350-355, 1985.
4. Gertz MA, Kyle RA: Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70: 246-256, 1991.
5. Torregrosa E, Hernández-Jaras J, Calvo C, Reus A, García-Pérez H, Maduell F, Vera JM. Amiloidosis secundaria (AA) y afectación renal. Nefrología 23: 321-26, 2003.
6. Simms RW, Prout MN, Cohen AS: The epidemiology of AL and AA amyloidosis. Baillieres Clin Rheumatol 8: 627-34, 1994.
7. Hazenberg BP, Van Rijswijk MH: Clinical and therapeutics aspects of AA amyloidosis. Baillieres Clin Rheumatol 8: 661-90, 1994.
8. Cazalets C, Cador B, Mauduit N, Decaux O, Ramee MP, Le Pogamp P, Laurent M, Jego P, Grosbois B: Epidemiological description of amyloidosis diagnosed at University Hospital of Rennes from 1995 to 1999. Rev Med Interne 24: 424-30, 2003.
9. Browning M, Banks R, Tribe C, Bacon P, Hollingworth P, Kingswood C, Poulding J, Harrison P, MacKenzie JC: Renal involvement in systemic amyloidosis. Proc Eur Dial Transplant Assoc 20: 595-602, 1983.
10. Kyle RA, Greipp PR: Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 58: 665-83, 1983.
11. Browning MJ, Banks RA, Tribe CR, Hollingworth P, Kingswood C, Mackenzie JC, Bacon PA: Ten years' experience of an amyloid clinicopathological survey. Q J Med 54: 213-27, 1985.
12. Hayman SR, Lacy MQ, Kyle RA, Gertz MA: Primary systemic amyloidosis: a cause of malabsorption síndrome. Am J Med 111: 535-40, 2001.
13. Hazenberg BP, Van Gameren II, Bijzet J, Jager PL, Van Rijswijk MH: Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med 62: 104-5, 2004.
14. Hachulla E, Grateau G. Diagnostic tools for amyloidosis. Joint Bone Spine 69: 538-45, 2002.
15. Kuroda T, Tanabe N, Sakatsume M, Nozawa S, Mitsuka T, Ishikawa H, Tohyama CT, Nakazono K, Murasawa A, Nakano N, Geijyo F: Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis. Clin Rheumatol 21: 123-8, 2002.
16. Duston MA, Skinner M, Reenan RF, Cohen AS: Sensitivity, specificity and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum 31: 82-5, 1989.
17. Duston MA, Skinner M, Shirahama T, Cohen AS: Diagnosis of amyloidosis by abdominal fat aspiration. Analysis of four's years' experience. Am J Med 82: 412-4, 1987.
18. Joss N, Mc Laughlin K, Simpson K, Boulton-Jones JM: Presentation, survival and prognostic markers in AA amyloidosis. QJM 93: 535-42, 2000.
19. Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, Yamasaki S, Ida H, Kawakami A, Origuchi T, Eguchi K: Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol 21: 343-6, 2003.
20. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM: Long - term survival (10 years or more) in 30 patients with primary amyloidosis. Blood 93: 1062-6, 1999.
21. Martínez-Vea A, García A, Carreras M, Revert L, Oliver JA: End-stage renal disease in systemic amyloidosis: clinical course and outcome on dyalisis. Am J Nephrol 10: 283-9, 1990.
22. Moroni G, Banfi G, Montoli A, Bucci A, Bertani T, Ravelli M, Pozzi C, Leonelli M, Lupo A, Volpi A y cols.: Chronic dialysis in patients with systemic amyloidosis: the experience in nothern Italy. Clin Nephrol 38: 81-5, 1992.
23. Gertz MA, Kyle RA, O'fallon WM: Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients. Arch Intern Med 152: 2245-50, 1992.
24. Ylinen K, Gronhagen-Riska C, Honkanen E, Elkstrand A, Metsarinne K, Kuhlback B: Outcome of patients with secondary amyloidosis in dyalisis treatment. Nephrol Dial Transplant 7: 908-12, 1992.